Skip to content

Medical emergency? What to do

CT scan risks in cystic fibrosis likely to rise

3-RXPublished January 28, 20063 min read

Key points

  • The increased cancer risk from annual CT scanning of patients with cystic fibrosis is currently modest, but will become more substantial as patients with the disease live longer, an international team of researchers reports.
  • CT scanning is more sensitive than simple chest X-rays in detecting structural lung damage and may also be more effective for identifying disease progression than measuring lung function, Dr.
  • Annual CT scanning beginning at age 2 years would reduce survival by 1 month for patients who lived to the age of 26.
  • Performing CT scans biannually reduced the associated mortality risk by half.

The increased cancer risk from annual CT scanning of patients with cystic fibrosis is currently modest, but will become more substantial as patients with the disease live longer, an international team of researchers reports.

Cystic fibrosis is a genetic disorder that affects the glands that produce sweat and mucus, with the most significant damage occurring in the lungs and digestive system. Mucus in cystic fibrosis patients becomes thick and accumulates in the lungs and intestines, resulting in breathing problems, frequent respiratory infections and poor nutrition. Because most patients die of lung disease, the primary goal of cystic fibrosis therapy is to help keep the airways clear and avoid respiratory infections.

CT scanning is more sensitive than simple chest X-rays in detecting structural lung damage and may also be more effective for identifying disease progression than measuring lung function, Dr. Pim A. de Jong and colleagues report in the American Journal of Respiratory and Critical Care Medicine. For these reasons, routine CT scans are increasingly being used in cystic fibrosis patients, but the benefits for survival are not clear.

Because cystic fibrosis patients are living longer, the researchers note, the cancer mortality risks associated with CT radiation would be expected to increase, de Jong, of Erasmus Medical Center in Rotterdam, and his colleagues point out. They therefore estimated the excess mortality associated with radiation exposure from CT scans, based on atom-bomb survivor data.

Annual CT scanning beginning at age 2 years would reduce survival by 1 month for patients who lived to the age of 26. Survival time due to radiation exposure would be reduced by 2 years if a patient survives to age 50, the researchers estimate.

Cumulative cancer mortality would be 2 percent at age 40 and 13 percent at age 65.

Performing CT scans biannually reduced the associated mortality risk by half.

The average lifespan for cystic fibrosis patients is estimated to be 50 years by 2030, the researchers note. "Given the potential reduction in survival associated with radiation exposure from routine CT scans, it would be important to further demonstrate the clinical benefits related to this approach to justify the use of routine lifelong CT scanning in patients with cystic fibrosis," they conclude.

In an editorial accompanying the study, Drs. Amy Berrington de Gonzalez and Jonathan Samet of Johns Hopkins School of Public Health in Baltimore call the estimated risks "surprisingly high."

They note that another strategy de Jong and colleagues did not address that could help reduce radiation exposure would be to limit scanning in children, when risks associated with radiation exposure are believed to be greater.

This would be especially important for girls with cystic fibrosis, given that the breast is highly sensitive to radiation, and more so at a young age.

There is currently no evidence that CT scans offer any survival benefits for cystic fibrosis patients, the editorialists note. "Studies of the potential survival benefits, preferably randomized controlled trials, therefore now need to be initiated so that any future risk of cancer will be justified by the benefits of the test," they conclude.

SOURCE: American Journal of Respiratory Critical Care Medicine, January 15, 2006.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.